RefBan

Referral Banners

Yashi

Tuesday, March 25, 2014

Reuters Health Report

Click to View in Browser
03/25/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Supreme Court hears religious challenge to Obamacare provision
WASHINGTON (Reuters) - The U.S. Supreme Court convened on Tuesday to consider whether business owners can object on religious grounds to a provision of President Barack Obama's healthcare law requiring employers to provide health insurance that covers birth control.
Pfizer lung cancer drug beats chemo for previously untreated patients
(Reuters) - Pfizer Inc's Xalkori delayed progression of lung cancer longer than chemotherapy in patients who had never previously been treated for the disease, according to results of a late-stage study released on Tuesday.
Pricier beef 'here to stay' as food costs seen higher: USDA
WASHINGTON (Reuters) - U.S. food prices are expected to rise more rapidly this year after a very tame 2013, led by gains in beef, poultry and egg prices, the U.S. Department of Agriculture said on Tuesday.
FDA staff review recommends against Novartis heart failure drug
WASHINGTON (Reuters) - A drug to treat acute heart failure made by Novartis AG should not be approved because there is insufficient evidence to show it improves symptoms, according to an initial review by the U.S. Food and Drug Administration.
Sanofi faces make-or-break verdict on big dengue vaccine bet
NEUVILLE-SUR-SAONE, France (Reuters) - Sanofi expects final clinical results for its vaccine against dengue by late September, the French drugmaker's project leader has told Reuters, and has already gambled on starting production despite some disappointing early trials data.
China's face mask industry under scrutiny as pollution worsens
HONG KONG (Reuters) - Chinese citizens are feverishly snapping up face masks as worsening air pollution fuels a multi-million dollar industry where many products fail to provide even basic protection, drawing calls for better oversight and standards.
Scientist who discovered Ebola frustrated by deadly Guinea outbreak
LONDON (Reuters) - Peter Piot was 27, newly qualified and working in a microbiology lab in Antwerp when he received a flask of human blood contaminated with a mysterious pathogen that had been killing people in the forests of Zaire.
Merck KGaA names new heads of lab equipment, OTC drugs units
FRANKFURT (Reuters) - Diversified healthcare and chemicals group Merck KGaA said the head of its Consumer Health unit, Udit Batra, would become chief executive of its much larger laboratory and biotech equipment unit Merck Millipore.
Brainsway sees growth in depression treatment, looks to new areas
JERUSALEM (Reuters) - Israeli medical device maker Brainsway expects strong growth following the launch of its treatment of depression and hopes to access new markets once its system finishes trials in treating a number of other diseases.
China's Hangzhou latest city to restrict car sales
BEIJING (Reuters) - China's eastern city of Hangzhou will start restricting car sales from Wednesday, joining major cities, including Shanghai and Beijing, in the fight against snarling traffic and heavy smog in the world's largest automobile market.
Related Video
Gulf shipping channels remain closed as oil spill cleanup continues
25th anniversary of Exxon Valdez spill
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika